Alzheimer's disease research, amyloid plaques, tau tangles, and cognitive decline
179 articles
Phase 1b trial tests escalating doses of experimental Alzheimer's treatment BMS-984923 for safety and tolerability in older adults.
Study tests VR therapy versus traditional cognitive training in 60 patients with mild cognitive impairment and Alzheimer's disease.
NGP 555 targets toxic brain protein production in healthy volunteers, offering potential early intervention for Alzheimer's prevention.
Brain scans reveal how testosterone suppression in prostate cancer treatment could lead to cognitive decline in aging men.
Clinical trial explores how targeted light treatment could restore circadian rhythms and improve brain function in mild cognitive impairment.
Major study reveals sleep breathing disorders may accelerate brain aging and memory decline, even before cognitive symptoms appear.
12-week intensive cognitive training program tested in 76 adults with early memory problems to assess brain function improvements.
SHARP program combines neighborhood walks with photo-prompted conversations to support Black dementia caregivers and patients together.
Novel movement program combining Eastern and Western exercises may help maintain independence and cognitive function in dementia patients.
Small trial tests electrical brain stimulation to improve sleep quality and cognitive function in patients with vascular dementia.
Small trial tested whether fish oil and alpha lipoic acid could slow Alzheimer's by reducing oxidative stress markers in blood.
Combining Mediterranean-DASH diet with nature therapy targets hypertension and cognitive decline in older adults.
